AMPIO PHARMACEUTICALS INC's ticker is AMPE and the CUSIP is 03209T109. A total of 83 filers reported holding AMPIO PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.59 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $616,000 | +6.2% | 364,714 | 0.0% | 0.00% | – |
| Q4 2020 | $580,000 | +2800.0% | 364,714 | +1679.1% | 0.00% | – |
| Q3 2020 | $20,000 | +53.8% | 20,500 | 0.0% | 0.00% | – |
| Q2 2020 | $13,000 | +44.4% | 20,500 | 0.0% | 0.00% | – |
| Q1 2020 | $9,000 | -25.0% | 20,500 | 0.0% | 0.00% | – |
| Q4 2019 | $12,000 | +20.0% | 20,500 | 0.0% | 0.00% | – |
| Q3 2019 | $10,000 | +25.0% | 20,500 | 0.0% | 0.00% | – |
| Q2 2019 | $8,000 | -33.3% | 20,500 | 0.0% | 0.00% | – |
| Q1 2019 | $12,000 | +50.0% | 20,500 | 0.0% | 0.00% | – |
| Q4 2018 | $8,000 | -20.0% | 20,500 | 0.0% | 0.00% | – |
| Q3 2018 | $10,000 | -77.8% | 20,500 | 0.0% | 0.00% | – |
| Q2 2018 | $45,000 | -35.7% | 20,500 | 0.0% | 0.00% | – |
| Q1 2018 | $70,000 | -15.7% | 20,500 | 0.0% | 0.00% | – |
| Q4 2017 | $83,000 | +538.5% | 20,500 | 0.0% | 0.00% | – |
| Q3 2017 | $13,000 | +18.2% | 20,500 | 0.0% | 0.00% | – |
| Q2 2017 | $11,000 | -31.2% | 20,500 | 0.0% | 0.00% | – |
| Q1 2017 | $16,000 | -11.1% | 20,500 | 0.0% | 0.00% | – |
| Q4 2016 | $18,000 | +20.0% | 20,500 | 0.0% | 0.00% | – |
| Q3 2016 | $15,000 | -42.3% | 20,500 | 0.0% | 0.00% | – |
| Q2 2016 | $26,000 | -43.5% | 20,500 | 0.0% | 0.00% | – |
| Q1 2016 | $46,000 | -36.1% | 20,500 | 0.0% | 0.00% | – |
| Q4 2015 | $72,000 | +22.0% | 20,500 | 0.0% | 0.00% | – |
| Q3 2015 | $59,000 | +20.4% | 20,500 | 0.0% | 0.00% | – |
| Q2 2015 | $49,000 | -55.9% | 20,500 | 0.0% | 0.00% | – |
| Q1 2015 | $111,000 | 0.0% | 20,500 | 0.0% | 0.00% | – |
| Q4 2014 | $111,000 | +54.2% | 20,500 | 0.0% | 0.00% | – |
| Q3 2014 | $72,000 | -57.9% | 20,500 | 0.0% | 0.00% | – |
| Q2 2014 | $171,000 | +47.4% | 20,500 | 0.0% | 0.00% | – |
| Q1 2014 | $116,000 | -23.7% | 20,500 | 0.0% | 0.00% | – |
| Q4 2013 | $152,000 | -6.2% | 20,500 | -5.1% | 0.00% | – |
| Q3 2013 | $162,000 | +29.6% | 21,600 | 0.0% | 0.00% | – |
| Q2 2013 | $125,000 | – | 21,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|